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ABSTRACT
Aim: To evaluate the relationship between vision-related
quality of life (VR-QOL) and visual function in patients
undergoing vitrectomy, gas tamponade and cataract
surgery for macular hole (MH).
Methods: The 25-item National Eye Institute Visual
Function Questionnaire (VFQ-25) was self-administered by
32 patients with MH (age 66.2 (SD 5.4) years)
preoperatively and at 3 months postoperatively. Clinical
data were collected, including logarithm of minimum
angle of resolution (logMAR) best corrected visual acuity
(BCVA), severity of metamorphopsia and letter contrast
sensitivity. The severity of metamorphopsia was eval-
uated by the M-Charts. MH index was measured using
optical coherence tomography. The presence and severity
of cataract were graded using the Lens Opacities
Classification System III reference standards. Multiple
regression analysis was performed to investigate the
relationship between various explanatory variables and
VFQ-25 questionnaire scores. Explanatory variables tested
were the severity of metamorphopsia, visual acuity, letter
contrast sensitivity, MH index and grade of cataract.
Results: Vitrectomy for MH significantly improved VFQ-
25 composite score as well as subscale scores, including
general vision, near activities, distance activities, social
functioning, mental health and dependency (p,0.05,
Wilcoxon signed-rank test). Multiple regression analysis
revealed that, both preoperatively and postoperatively, the
severity of metamorphopsia had a significant correlation
with VFQ-25 composite score (p,0.05), whereas other
explanatory variables did not. In addition, changes in the
severity of metamorphopsia was the single variable that
was significantly related to changes in VFQ-25 composite
score (p,0.01).
Conclusion: Vitrectomy for MH significantly improved
VR-QOL. The severity of metamorphopsia was significantly
associated with both preoperative and postoperative VR-
QOL.
Visual acuity improves in many patients after
successful closure of macular hole (MH) by
vitrectomy,1 2 whereas some patients still complain
of remaining metamorphopsia after surgery.
Metamorphopsia is one of the most common
conditions that cause deterioration in visual func-
tions in patients with macular diseases. Relatively
little attention has been paid, however, to changes
in visual functions, including metamorphopsia,
caused by surgery and their relationship with
vision-related quality of life (VR-QOL).
Recent studies using the 25-item National Eye
Institute Visual Function Questionnaire (VFQ-25)
have reported that vitrectomy for MH appears to
have a beneficial effect on patients’ subjective
perception of quality of life.3–5 Tranos et al
demonstrated that VFQ-25 score after MH surgery
was significantly correlated with the severity of
postoperative metamorphopsia.4 On the other
hand, preoperative and surgery-induced changes
in VFQ-25 composite score did not correlate with
the preoperative severity of metamorphopsia or
changes in the severity.4 They evaluated the
severity of metamorphopsia using the Amsler
chart, which has been widely used to detect and
evaluate metamorphopsia in patients with macular
diseases.6 7 With the Amsler chart, however, it is
difficult to quantify the severity of metamorphop-
sia because the patients have to self-describe the
degree of image distortion. Assessment with the
M-Charts (Inami Co., Tokyo, Japan) can easily and
quantitatively evaluate the degree of metamor-
phopsia associated with macular diseases, as the
patients only have to state whether the line
appears to be distorted or not.8 9 We conducted
the current prospective study to evaluate the
relationship between VR-QOL and visual function,
including metamorphopsia, using the M-Charts in
patients undergoing vitrectomy for MH.
PATIENTS AND METHODS
The current prospective, consecutive case series
included 32 eyes of 32 patients with MH (13 men
and 19 women) who underwent pars plana
vitrectomy at Tsukuba University Hospital
between June 2006 and February 2007. Patients
with other ocular diseases, except for mild refrac-
tive error, were excluded. There were no significant
ocular pathologies in the fellow eyes of the
patients. Logarithm of minimum angle of resolu-
tion (logMAR) best corrected visual acuity
(BCVA), the severity of metamorphopsia and letter
contrast sensitivity were recorded preoperatively
and at 3 months postoperatively.
The severity of metamorphopsia was evaluated
by the M-Charts. The M-Charts consist of 19
dotted lines with dot intervals ranging from 0.2u to
2.0u of visual angle. If the straight line is
substituted with a dotted line and the dot interval
is changed from fine to coarse, the distortion of the
line decreases with the increasing dot interval,
until finally the dotted line appears straight.8 9
Letter contrast sensitivity was measured using
the CSV-1000LV chart (Vector Vision, Columbus,
Ohio, USA). Measurements with optical coherence
tomography (OCT; Stratus OCT 3000, Carl Zeiss
Ophthalmic Systems-Humphrey Division, Dublin,
California, USA) were carried out preoperatively.
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Three MH parameters (MH base diameter, MH diameter and
retinal thickness around the MH) were defined and the MH
index (MHI) was calculated according to the methods of
Kusuhara et al.10 For standardisation purposes, several OCT
images were recorded on each occasion. The presence and
severity of cataract were graded using the Lens Opacities
Classification System III (LOCS III) reference standards.11
The patients were requested to answer VFQ-25 preopera-
tively and at 3 months postoperatively to assess VR-QOL.12 The
research staff explained the questionnaire to the patients, and
gave verbal instructions and provided assistance when required.
The completed questionnaires were reviewed for missing data
by the research staff. Prior to surgery, all missing data were
added by the patients themselves. The VFQ-25 comprises 25
items wherein patients are expected to assess the level of
difficulty of particular visual symptoms or day-to-day activities.
Each item is assigned to one of the 12 subscales: general health,
general vision, ocular pain, near activities, distance activities,
social functioning, mental health, role difficulties, dependency,
driving, colour vision and peripheral vision. The subscales are
scored on a 0 to 100 point scale, where 100 indicates the highest
possible function or the minimal subjective impairment. The
VFQ-25 composite score is calculated as the unweighted average
response to all items, excluding questions regarding general
health. The VFQ-25 used in this study was a Japanese version,
with modifications to suit the Japanese culture and way of life.
The modified NEI VFQ-25 questionnaire has been assessed for
reliability and validity, and it has been proven to accurately
measure VR-QOL in Japanese individuals.13
Surgeries were performed by an experienced vitreoretinal
surgeon (F O), using standard cataract surgery and pars plana
vitrectomy with 20 gauge probes, peeling of the inner limiting
membrane with subsequent instillation of a gas tamponade
(20% sulphur hexafluoride; SF6) and postoperative instructions
to lie face down for 1 week. Indocyanine green was used to peel
the inner limiting membrane. Subjects were followed up for at
least 3 months after surgery and any postoperative complica-
tions were documented.
Mean scores and standard deviations were calculated for
VFQ-25 composite and subscale scores, visual acuity, severity of
metamorphopsia, contrast sensitivity, MHI and LOCS III index.
The significance of the differences between preoperative and
postoperative values was assessed with the Wilcoxon signed-
rank test. Preoperatively and postoperatively, multiple regres-
sion analysis was performed to investigate the relationship
between various explanatory variables and VFQ-25 question-
naire scores. Variables tested were visual acuity, severity of
metamorphopsia, letter contrast sensitivity, MHI and grade of
cataract (LOCS III index). The relationship between changes in
VFQ-25 composite score and changes in above-mentioned
explanatory variables was also evaluated. All statistical tests
were considered to be significant if p,0.05. Analyses were
carried out using StatView (version 5.0; SAS Institute, Cary,
North Carolina, USA). A prestudy power calculation using a
significance level of 5% (a) and a power of 80% (1–b) revealed
that a sample size of 27 eyes would be required to detect a mean
VFQ-25 composite score difference of 6 points.
RESULTS
Table 1 summarises the preoperative characteristics of patients.
By the initial surgery, MH was successfully closed in all eyes. No
significant intraoperative and postoperative complications were
observed, such as retinal detachment, choroidal detachment,
subretinal haemorrhage, cystoid macular oedema or infection.
In six patients, intraocular pressure elevated to 25 mmHg or
higher, but responded promptly to antihypertensive therapy.
All patients underwent MH surgery on their worse-seeing
eyes. The surgery significantly improved the metamorphopsia
score from 0.77 (SD 0.55) to 0.45 (SD 0.44) (p,0.005, Wilcoxon
signed-rank test), logMAR BCVA from 0.76 (SD 0.47) to 0.48
(SD 0.35) (p,0.0001), and letter contrast sensitivity from 15.3
(SD 8.8) to 19.5 (SD 8.2) (p,0.005). Metamorphopsia was
significantly improved by surgery, but did not resolve com-
pletely at 3 months after surgery.
The results of the pre- and postoperative VFQ-25 question-
naire are shown in table 2. Vitrectomy significantly improved
VFQ-25 composite score (p,0.005), as well as subscales such as
general vision (p,0.0005), near activities (p,0.001), distance
activities (p,0.05), social functioning (p,0.01), mental health
(p,0.05) and dependency (p,0.01).
Table 3 summarises the results of multiple regression analysis
on the relationship between VFQ-25 composite score and
several explanatory variables, including visual function, MH
morphology and grade of cataract. Both preoperatively and
postoperatively, the severity of metamorphopsia exhibited
significant positive correlation with VFQ-25 composite score
(p,0.05), whereas other explanatory variables showed no
relationship with VFQ-25 composite score. Similarly, changes
in the severity of metamorphopsia were significantly associated
with the changes in VFQ-25 composite score (p,0.01, fig 1), but
changes in other variables were not, including logMAR BCVA
(fig 2) and letter contrast sensitivity (fig 3).
DISCUSSION
As shown in the results, vitrectomy for MH significantly
improved VFQ-25 composite score and subscale scores including
general vision, near activities, distance activities, social func-
tioning, mental health and dependency. This observation is
consistent with the results of previous studies that also
investigated VR-QOL in patients with MH.3–5
In the current study, multiple regression analysis revealed
that the severity of metamorphopsia was significantly asso-
ciated with VFQ-25 composite score, both preoperatively and
postoperatively, while other variables were not related, such as
visual acuity, letter contrast sensitivity, MHI and grade of
cataract (LOCS III index). Further, changes in the severity of
metamorphopsia were significantly correlated with changes in
VFQ-25 composite score. These findings are not consistent with
Table 1 Preoperative characteristics of patients with macular hole
Variable Value
Age (years) 66.2 (5.4)
Male/female (n/n) 13/19
LogMAR BCVA in worse-seeing eye (operated eye) 0.76 (0.47)
LogMAR BCVA in better-seeing eye (fellow eye) 0.04 (0.26)
Stage of macular hole (II/III/IV) (n) 7/16/9
LOCS III (scale 0.1–5.9)
Nuclear colour 1.20 (0.3)
Nuclear opalescence 0.60 (0.8)
Cortical opacity 0.86 (1.0)
Posterior subcapsular opacity 0.27 (0.4)
Severity of metamorphopsia 0.77 (0.55)
Letter contrast sensitivity 15.3 (8.8)
Macular hole index 0.81 (0.56)
Values are mean (SD).
BCVA, best corrected visual acuity; LOCS III, Lens Opacities Classification System III;
LogMAR, logarithm of minimum angle of resolution.
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the results of a previous study.4 Tranos et al investigated VR-
QOL in patients with MH and reported that postoperative
VFQ-25 scores were significantly correlated with the severity of
postoperative metamorphopsia recorded by measuring the
number of squares representing distortion on the Amsler chart.
However, preoperative and surgery-induced changes in VFQ-25
composite score were not associated with preoperative and
changes in the severity of metamorphopsia.4 The discrepancy
between our study and the previous studies may be attributable
to the different methodology used to evaluate metamorphopsia.
In previous studies, the severity of metamorphopsia was graded
using the Amsler charts, which have been widely used to detect
metamorphopsia in macular diseases.6 7 With the Amsler chart,
however, precise and reproducible assessment of metamorphop-
sia is difficult because patients have to self-describe the degree of
image distortion. On the other hand, the M-Charts can evaluate
the degree of metamorphopsia quantitatively since patients
need simply to answer whether the dotted line is distorted or
not. With this chart, the degree of metamorphopsia is graded
quantitatively from 0 to 2.0.8 9 It has been reported that the
metamorphopsia score recorded by the M-charts increased
depending on the severity of membrane proliferation classified
by scanning laser ophthalmoscope images in patients with
epiretinal membrane.8 Another study demonstrated that there
was a significant positive correlation between the degree of
retinal contraction obtained by using image-analysis software
and metamorphopsia score quantified by the M-charts in
patients with idiopathic epiretinal membrane.9
Preoperative, postoperative and surgery-induced changes in
VFQ-25 scores did not correlate with visual acuity in both the
better- and worse-seeing (operated) eyes. Miskala et al measured
VFQ-25 in patients with subfoveal choroidal neovascularisation
caused by age-related macular degeneration, and demonstrated
that VFQ-25 subscale scores were significantly correlated with
visual acuity in the better-seeing eyes, but not with visual
acuity in the worse-seeing eyes.14 In patients with unilateral
central retinal vein occlusion, Deramo et al reported that VFQ-
25 responses were significantly correlated with visual acuity in
the better-seeing eyes.15 In patients with early glaucoma with
similar visual acuity bilaterally, Hyman et al demonstrated that
VFQ-25 responses were significantly correlated with visual
acuity in both the better- and worse-seeing eyes.16 Conversely,
multiple regression analysis in the current study revealed that
the severity of metamorphopsia was the single factor relevant to
VR-QOL in patients with MH, while visual acuity was not
included among the relevant factors. Moreover, the presence
and severity of cataract were not associated with VR-QOL.
Thus, metamorphopsia plays a key role in the deterioration of
visual functioning and VR-QOL in patients with MH, even after
successful closure of MH by vitrectomy. The severity of
metamorphopsia after vitrectomy was actually 0.45 (SD 0.44),
which is abnormally worse compared with normal controls.8 9
We found no association between letter contrast sensitivity
and VFQ-25 composite score before and after surgery. Ghazi-
Nouri et al reported that VFQ-25 responses correlated with
visual acuity but not with contrast sensitivity obtained with
the Pelli–Robson chart in patients with epiretinal membrane.17
In patients with proliferative diabetic retinopathy, VFQ-25
composite scores showed significant correlations with letter
Table 2 The National Eye Institute 25-item Visual Function
Questionnaire (VFQ-25) composite and 12 subscale scores in patients
with macular hole
VFQ-25 scale
VFQ-25 scores
Before surgery After surgery p Value
Composite score 70.5 (17.1) 77.4 (11.2) 0.002*
General health 49.2 (14.6) 50.0 (14.2) 0.763
General vision 53.7 (15.6) 68.1 (13.3) 0.001*
Ocular pain 81.6 (16.7) 84.3 (14.9) 0.240
Near activities 58.6 (19.2) 70.1 (16.8) 0.001*
Distance activities 62.2 (19.0) 69.7 (16.1) 0.019*
Social functioning 77.4 (15.2) 82.8 (13.4) 0.007*
Mental health 66.0 (21.1) 75.4 (12.7) 0.015*
Role difficulties 69.9 (21.7) 76.2 (21.6) 0.053
Dependency 82.0 (17.7) 89.6 (11.0) 0.008*
Driving 72.2 (18.4) 76.7 (15.2) 0.667
Colour vision 85.1 (14.0) 86.7 (16.8) 0.617
Peripheral vision 66.4 (17.5) 73.0 (18.0) 0.065
Values are mean (SD).
*Significantly improved by surgery (Wilcoxon signed-rank test).
Figure 1 Statistically significant correlation between changes in the
severity of metamorphopsia and changes in the 25-item National Eye
Institute Visual Function Questionnaire (VFQ-25) composite score by
vitrectomy for macular hole (p,0.01, multiple regression analysis).
Figure 2 No significant correlation was found between changes in
logarithm of minimum angle of resolution (logMAR) best corrected visual
acuity (BCVA) and changes in the 25-item National Eye Institute Visual
Function Questionnaire (VFQ-25) composite score by vitrectomy for
macular hole (p.0.05, multiple regression analysis).
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contrast sensitivity, as well as visual acuity.18 In patients after
retinal reattachment surgery, VFQ-25 composite score was
significantly correlated with contrast sensitivity and low-
contrast visual acuity, whereas there was no correlation
between the VFQ-25 composite score and BCVA.19 In a
heterogeneous group of patients with multiple sclerosis,
VFQ-25 composite scores were found to be modestly and
significantly correlated with several clinical parameters, includ-
ing visual acuity, contrast sensitivity, visual field, and 100-Hue
colour vision.20 In patients with Bothnia dystrophy, a defined
type of retinitis pigmentosa, age and low contrast visual acuity
were significantly associated with the NEI-VFQ-25 composite
score.21 Thus, factors contributing to VR-QOL are not uniform
across different type of ocular diseases, and therefore it seems
worthwhile to investigate individual diseases from the view
point of VR-QOL.
We acknowledge certain limitations to our study. First, the
sample size in our study was rather small. Second, postoperative
follow-up was short. A previous study showed that VFQ-25 in
patients with MH was more improved at 1 year postoperatively
than at 3 months postoperatively.3 Moreover, metamorphopsia
might have further improved with a longer follow-up. Tranos et
al reported, however, that 65% of patients complained of
metamorphopsia at 4 months after surgery.4 Future studies
with a larger sample size and longer follow-up time will further
facilitate our understanding of the relationship between VR-
QOL and visual function, and other factors, in patients
undergoing vitrectomy for MH.
In conclusion, the current study quantitatively indicated that
MH surgery significantly improved VR-QOL, which was
dependent on the improvement of metamorphopsia. The
severity of preoperative and postoperative metamorphopsia
was significantly correlated with preoperative and postoperative
VFQ-25 scores, respectively. Metamorphopsia is an important
factor not only in visual functioning, but also in the subjective
Figure 3 No significant correlation was found between changes in
letter contrast sensitivity and changes in the 25-item National Eye
Institute Visual Function Questionnaire (VFQ-25) composite score by
vitrectomy for macular hole (p.0.05, multiple regression analysis).
Table 3 Results of multiple regression analysis on the National Eye Institute 25-item Visual Function
Questionnaire (VFQ-25) composite score and explanatory variables
Variable b SE p Value
Preoperative VFQ-25 composite score (objective variable)
Explanatory variable
LogMAR BCVA in the better-seeing eye 20.173 8.910 0.419
LogMAR BCVA in the worse-seeing eye 0.020 6.704 0.933
Letter contrast sensitivity in the better-seeing eye 0.236 3.132 0.332
Letter contrast sensitivity in the worse-seeing eye 20.073 0.390 0.753
Metamorphopsia 20.479 4.348 0.019*
Macular hole index 20.252 4.896 0.249
Lens nuclear colour 0.183 13.997 0.614
Lens nuclear opalescence 0.163 4.066 0.567
Lens cortical opacity 0.131 2.619 0.535
Lens posterior subcapsular opacity 20.301 7.559 0.199
Postoperative VFQ-25 composite score (objective variable)
Explanatory variable
LogMAR BCVA in the better-seeing eye 20.360 8.996 0.1270
LogMAR BCVA in the worse-seeing eye 20.217 8.333 0.385
Letter contrast sensitivity in the better-seeing eye 20.126 3.611 0.672
Letter contrast sensitivity in the worse-seeing eye 20.254 0.848 0.277
Metamorphopsia 20.563 7.228 0.049*
Macular hole index 0.117 5.306 0.636
Lens nuclear colour 20.069 14.587 0.849
Lens nuclear opalescence 0.045 4.563 0.893
Lens cortical opacity 0.240 2.600 0.280
Lens posterior subcapsular opacity 20.238 7.463 0.329
Changes in the VFQ-25 composite score (objective variable)
Explanatory variable
Changes in logMAR BCVA 20.151 7.274 0.402
Changes in letter contrast sensitivity 20.087 0.291 0.621
Changes in metamorphopsia 20.594 4.177 0.002*
b, standard regression coefficient; BCVA, best corrected visual acuity; SE, standard error.
*Significant at p,0.05.
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QOL in patients with MH, both preoperatively and post-
operatively.
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